Compound Detail
CHEMBL564085
TROLEANDOMYCIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
Basic Information
| ChEMBL ID | CHEMBL564085 |
| Name | TROLEANDOMYCIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LQCLVBQBTUVCEQ-QTFUVMRISA-N |
| Therapeutic | ✓ Yes |
2
Targets
11
Activities
2
Assay Types
0
PK Parameters
20
Publications
8
Known Names
2
Indications
1
Mechanisms
Molecular Properties
814.0
MW (Da)
3.62
ALogP
16
HBA
0
HBD
184.2
PSA (Ų)
0.19
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1969 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| 70S ribosome inhibitor | INHIBITOR | 70S ribosome | ✓ | ✓ |
Indications
Bacterial Infections Osteomyelitis
ATC Classification
J01FA08
troleandomycin
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE
Activity Summary
IC50 8 meas. best 5.1
Ki 3 meas. best 4.06
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 5.1 | 4.658 | 7998.3 | 5 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 4.17 | 4.1133 | 68300.0 | 3 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | Ki | 4.06 | 4.06 | 87640.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 12930139 | 10.1021/jm034111v | Cytochrome P450 3A4 | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 3 |
| 11716514 | 10.1006/bbrc.2001.6000 | ATP-dependent translocase ABCB1 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 22931300 | 10.1021/tx300075j | Cytochrome P450 3A4 | 2 |
| 11961113 | 10.1124/mol.61.5.964 | ATP-dependent translocase ABCB1 | 2 |
| 12235267 | 10.1124/jpet.102.037549 | ATP-dependent translocase ABCB1 | 2 |
| 22931300 | 10.1021/tx300075j | Liver microsomes | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
| 22931300 | 10.1021/tx300075j | Cytochrome P450 2D6 | 1 |
Data from ChEMBL 36 via Core Engine